Ravi B. Patel
Myriad (Germany)(DE)University of Pittsburgh(US)Bay Medical Center(US)Myriad Genetics(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Radiopharmaceutical Chemistry and Applications, Immunotherapy and Immune Responses, Peptidase Inhibition and Analysis, Cell Adhesion Molecules Research
Most-Cited Works
- → Development of an In Situ Cancer Vaccine via Combinational Radiation and Bacterial‐Membrane‐Coated Nanoparticles(2019)225 cited
- → Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade(2021)218 cited
- → Considerations for treatment duration in responders to immune checkpoint inhibitors(2021)131 cited
- → Effect of injection site on in situ implant formation and drug release in vivo(2010)119 cited
- → Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma(2015)109 cited
- → Complications from Stereotactic Body Radiotherapy for Lung Cancer(2015)103 cited